PRLog - March 12, 2014 - PORTLAND, Ore. -- As per the study conducted by Allied Market Research, global umbilical cord blood stem cell market is expected to reach $11.5 billion in 2014 from $6.5 billion in 2012. Further, it is expected to reach $56.4 billion by 2020 growing at a CAGR of 33.4%.
2014_ 9661294_ 12cellEmbryo_ AcidShockUnderScru
GEt full access of report at: http://www.bigmarketresearch.com/
Global stem cell market is dominating the healthcare industry with its reliable and cost effective method of treatment with fewer side effects. Umbilical cord blood stem cells are one of the potential segments of stem cell market for growth in future. Other segments of this market include - Adult stem cell and embryonic stem cells. Cord blood is one of the rich sources of stem cells, which are treated as waste after pregnancy or childbirth; however, this blood has huge potential to treat chronic diseases such as cancer, diabetes, blood disease immune diseases, etc.
More than 80 genetic diseases were treated with cord blood in current scenario. Government authorities are supporting the research and clinical trials of cord blood stem cell, which is currently increasing the interest of healthcare companies to invest in research and commercialization of cord blood stem cell therapies. Competition is currently intense with companies trying to create brand awareness.
Table Of Contents:
3.STEM CELL UMBILICAL CORD BLOOD (UCB) Market Overview
4.STEM CELL UMBILICAL CORD BLOOD (UCB) Market by storage service
5.STEM CELL UMBILICAL CORD BLOOD (UCB) market by therapeutics
6.STEM CELL UMBILICAL CORD BLOOD (UCB) Market by Application
7.STEM CELL UMBILICAL CORD BLOOD (UCB) Market by Geography
+1 (617) 674-4143
+1 (617) 674-4143